Alzheimer’s Disease – Page 6 – Waisman Center – UW–Madison

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer’s disease in Down syndrome

The Alzheimer’s Biomarker Consortium-Down Syndrome: Rationale and methodology

Cerebrospinal fluid biomarkers of Alzheimer’s disease in a cohort of adults with Down syndrome

Cortical Microstructural Alterations in Mild Cognitive Impairment and Alzheimer’s Disease Dementia.

Amyloid accumulation in Down syndrome measured with amyloid load

Metabolic correlates of prevalent mild cognitive impairment and Alzheimer’s disease in adults with Down syndrome

Epidemiology of Dementia and Alzheimer Disease in Individuals With Down Syndrome.

Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.

Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case report.

Leisure Activity, Brain β-amyloid, and Episodic Memory in Adults with Down Syndrome